Dual-energy X-ray Absorptiometry Market Size & Share 2025 - 2034

Dual-energy X-ray Absorptiometry Market Size

The global dual-energy x-ray absorptiometry market size was valued at USD 656.7 million in 2024 and is expected to reach USD 1.43 billion in 2034, growing at a CAGR of 8.1% from 2025 to 2034. Dual-energy x-ray absorptiometry (DEXA) is a medical imaging technique used to measure and analyze the density of bone and body composition. This system is used to assess bone health, especially for diagnosing osteoporosis and monitoring changes in bone density over time.

The osteoporosis around the world is increasing, which is leading to higher demand for dual-energy x-ray absorptiometry systems in developed as well as emerging nations. For instance, according to the Australian Institute of Health and Welfare, in 2022, Australia was estimated to have around 853,600 individuals suffering from osteoporosis. Including the missing diagnoses, the actual number is probably much greater. Moreover, there is a rise in the deficiency of vitamin D in individuals across the globe. This is due to various reasons such as limited exposure to sun as well as dietary deficiencies. Also, aging populations have limited capacity to produce vitamin D, and their lifestyle is mostly indoor. According to the data from National Library of Medicine, approximately one billion people have a deficiency of vitamin D, while 50% of the world suffers from an insufficient amount of vitamin D. Such statistics show that there is a need for early detection as well as monitoring, which is expected to expand the adoption of DEXA systems in healthcare facilities worldwide.
 

Moreover, the number of old aged people is increasing worldwide, and it is also one of the reasons fuelling the requirement for DEXA systems. Elderly individuals have greater risks of osteoporosis and fractures as their bone mineral density (BMD) is less. The United Nations has predicted that the people over 65 will be increasing from 761 million in 2021 to 1.6 billion by 2050. In addition, the International Osteoporosis Foundation (IOF) reveals that every fourth woman and every fifth man above fifty years is likely to have osteoporotic fractures. The growing demand for early detection, fracture risk assessment and monitoring of bone health is anticipated to increase the use of DEXA systems across hospitals, diagnostic centers, and specialized clinics.
 

 Dual-energy X-ray Absorptiometry Market Trends

• Bone densitometry is advancing, and key players are adopting modern technologies. They are promoting these to the end users to maximize their revenue.
   
• For instance, in February 2024, FUJIFILM India set up its FDX Visionary-DR DEXA system at Center for Sports Injuries located in Delhi, a medical facility in sports medicine, orthopedic surgery, and rehabilitation. This advanced unit enables rapid and detailed scanning of bone density which is necessary for a proper diagnosis and treatment as well.
   
• Moreover, organizations are pushing for better insurance reimbursement to improve patient access to DEXA scans. For instance, the National Osteoporosis Foundation (NOF) and the Association of Women in Rheumatology (AWIR) are advocating for higher Medicare reimbursement rates to ensure that more individuals, particularly seniors, can afford osteoporosis screening and early detection. These efforts are expected to boost DEXA adoption in hospitals and diagnostic centers.
   
• Furthermore, AI-powered DEXA software solutions are enhancing automated bone density analysis, fracture risk assessment, and body composition tracking. Advanced algorithms help clinicians make faster and more precise diagnoses, reducing human error and optimizing patient management.
   
• For instance, Horizon DXA by Hologic integrates AI-driven software to enhance automated bone density analysis, fracture risk assessment, and body composition tracking. The system utilizes computer-assisted diagnosis (CAD) tools to improve the accuracy of osteoporosis detection and fracture prediction, enabling clinicians to make faster and more reliable treatment decisions.
   
• Additionally, AI-powered body composition analytics helps to assess fat distribution, muscle mass, and metabolic health, expanding DEXA's applications beyond osteoporosis screening into areas such as sports medicine and obesity management.
   

Dual-energy X-ray Absorptiometry Market Analysis

Based on type, the dual-energy X-ray absorptiometry (DEXA) market is segmented into total axial DEXA bone densitometer and peripheral DEXA bone densitometer. The global market for dual-energy X-ray absorptiometry (DEXA) was valued at USD 608.7 million in 2023. The axial DEXA bone densitometer segment dominated the market with the largest revenue of USD 355.2 million in 2024.
 

• These systems have achieved immense popularity because of the exceptional accuracy with which they evaluate bone mineral density (BMD) at critical skeleton areas such as the spine and hip, which are essential in osteoporosis diagnosis and fracture risk evaluation.
   
• Moreover, in comparison to peripheral systems, axial DEXA achieves the best accuracy and reproducibility of osteoporosis screening and treatment monitoring, which makes it the gold standard. Its extensive clinical applications in sports medicine and obesity management are due to its capability to provide comprehensive analysis of body composition including body fat and lean mass.
   
• Furthermore, the increasing aged demographics coupled with rising incidence of osteoporosis remains the primary drivers fuelling the segment growth. The Center for Disease Control and Prevention (CDC) suggests that the U.S. alone has approximately 12.6% of adults, aged 50 and above, that have pernicious osteoporosis of the femur, neck, or lumbar spine which needs early diagnosis and sustained follow up with periodic axial DEXA scans.
   

Based on type, the dual-energy X-ray absorptiometry market is segmented into standalone and portable. The standalone segment emerged as a dominant segment in the market, accounting for 59.4% of revenue share in 2024 and is expected to reach by USD 865.5 million by 2034.
 

• These systems are implemented in hospitals, diagnostic centers and research facilities because of their accuracy, imaging strength, and holistic bone density analysis.
   
• Standalone DEXA scanners are very useful in the diagnosis of osteoporosis, and evaluation of the patient’s risk of fracture. Low dosage radiation is being used by key players in these systems.
   
• For instance, the feature of low dosage radiation, coupled with super accurate body composition analysis and bone density measurement is provided by GE Healthcare’s Prodigy series DEXA systems.
   
• Hospitals and research institutions use this system for diagnosing osteoporosis, assessing the patient’s metabolic health, and it ensures patient safety, and accurate diagnostics.
   

Based on application, the dual-energy X-ray absorptiometry market is segmented into osteoporosis, body composition analysis, fracture management, bone densitometry, and other applications. Osteoporosis segment dominated the market accounting for USD 238 million in 2024.
 

• Osteoporosis is a dominating segment as the prevalence of the condition is continually on the rise, particularly among the aging population.
   
• For instance, according to the International Osteoporosis Foundation, approximately 200 million women worldwide are affected by osteoporosis, leading to significant health challenges and these women have an increased risk of fractures as well.
   
• Moreover, it has been known that the most profound complication of osteoporosis is fracture. According to National Center for Biotechnology Research, it was projected that by 2050, the incidence of hip fracture in men would increase by 310% and 240% in women, globally.
   
• Moreover, the increasing awareness of bone health and the importance of early diagnosis have further boosted the segment's growth.
   

Based on end use, the dual-energy X-ray absorptiometry market is segmented into hospitals and clinics, diagnostic centers, specialty centers, and other end users. Hospitals and clinics segment accounted for the largest revenue share of 43.5% in 2024.
 

• Medical facilities such as hospitals and clinics are the initial healthcare points where several patients, the majority being the elderly, go for diagnosis and treatment procedures.
   
• Considering the large number of people suffering and aging, DEXA systems are used extensively in these centers for proper diagnosis and monitoring of osteoporosis.
   
• The combination of sophisticated medical equipment and the availability of experienced medical personnel in the hospitals and clinics greatly increases the use of DEXA systems in these institutions.
   

The U.S. dual-energy x-ray absorptiometry market revenue has increased considerably from USD 212.6 million in 2023 and is expected to grow significantly, reaching USD 489.2 million by 2034.
 

• The high prevalence of osteoporosis in the U.S. is a significant contributor in the growth of this market. For instance, according to the Bone Health and Osteoporosis Foundation, roughly 10 million adults aged 50 and older have osteoporosis, and an additional 44 million have low bone mass, increasing their risk of fractures.
   
• Moreover, Medicare and private insurance providers pay for bone density scans for high-risk patients and groups like the International Osteoporosis Foundation are lobbying to raise Medicare funding, broadening the use of DEXAs in multiple healthcare facilities.
   

Europe: The UK dual-energy X-ray absorptiometry market is projected to experience steady growth between 2025 and 2034.
 

• The rise in osteoporosis in the UK is creating a demand for DEXA systems in the country. For instance, as per the data from the International Osteoporosis Foundation, 21.9% of females and 6.7% of males over fifty years of age are diagnosed with osteoporosis, which underscores the need for pre-emptive strategies in identification as well as intervention.
   
• Moreover, the rising emphasis on preventative care services is driving the use of DEXA in bone health management and assessment of fracture risks. For instance, availability of FRAX (fracture risk assessment tool) in the UK helps to increase the awareness and use of bone densitometry through DEXA scans.
   
• Furthermore, the increased spending on diagnostic imaging by the National Health Service which subsequently increases the number of DEXA machines in NHS Trust hospitals, is also driving the market growth.
   

Asia Pacific: Japan’s dual-energy X-ray absorptiometry market is poised to witness lucrative growth between 2025 – 2034.
 

• Japan has a massive aging society according to estimates from Statista, as of November 2023, around 36.35 million people in Japan were estimated to be over 65 years of age.
   
• Therefore, it is expected that an aging society will heavily affect the osteoporosis burden in Japan in near future, further fostering the IV solution market.
   

Middle East and Africa: The dual-energy X-ray absorptiometry market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
 

• Saudi Arabia is also experiencing a shift in population demographics. For instance, the number of people aged 60+ is expected to increase five times from 2 million (5.9% of the total population) in 2020, reaching 10.5 million by 2050.
   
• Thus, as the geriatric people are more susceptible to osteoporosis, such high trends in the aging population are expected to increase the demand for dual-energy X-ray absorptiometry (DEXA) in coming years.
   

 Dual-energy X-ray Absorptiometry Market Share

The dual-energy X-ray absorptiometry (DEXA) market is largely dominated by the top 4 players which include GE Healthcare, Fujifilm, OSTEOSYS, and Diagnostic Medical Systems (DMS), accounting for approximately 60% of the market share in 2024. These are involved in product innovations, along with strategic collaborations. Partnerships with hospitals, research institutions, and healthcare organizations play a crucial role in expanding market reach, ensuring regulatory compliance, and advancing bone densitometry technology. These players pay attention to imaging accuracy and are promoting software integration. Additionally, the growing emphasis on digital health solutions and telemedicine integration is pushing market players to develop connected DEXA systems that support remote diagnostics and seamless data sharing between healthcare providers.
 

Dual-energy X-ray Absorptiometry Market Companies

Some of the eminent market participants operating in the dual-energy X-ray absorptiometry (DEXA) industry include:

• Aurora Spine
• BeamMed
• DMS
• Fonar
• Fujifilm
• Furuno Electric
• GE Healthcare
• Hologic
• Medilink International
• Medonica
• Osteometer Meditech
• OSTEOSYS
• Scanflex Healthcare
• Shenzhen XRAY Electric
• Swissray Medical
• Xingaoyi
   
• Fujifilm Holdings Corporation continues to expand its presence in the market through technological innovation and strategic acquisitions. For instance, the Hitachi’s diagnostic imaging business was acquired by Fujifilm in March 2021, which has enhanced its portfolio including bone densitometry systems.
   
• OSTEOSYS has a strong global footprint in the dual-energy x-ray absorptiometry market. The company has a global presence with distribution across over 70 countries.
   

Dual-energy X-ray Absorptiometry Industry News

• In February 2022, Aurora Spine partnered with Echolight Medical, the manufacturer of the radiation-free EchoS portable densitometer utilized to assess the quality of the software platform and the bone mineral density (BMD) in the patients affected. The two companies decided to advertise one other's products to their respective clients and prospects as part of the Aurora DEXA Platform. This partnership helped both companies to accelerate business revenue growth within the DEXA market.
   
• In May 2019, Hologic Inc., partnered with DEXA+ for distribution of its Horizon DXA system for body composition measurement including total lean mass, body fat percentage, and limb comparison to detect muscle imbalances. Through this partnership, Hologic broadened its customer base in a significant market.
   
• In October 2019, Fujifilm Medical Systems launched a new suite of dual-energy X-ray absorptiometry (DEXA) systems in the U.K. This range includes the FDX Visionary-A, a pencil beam system for osteoporosis diagnosis and fracture risk evaluation. This range also includes the FDX Visionary-DR, a fan beam system that has, better diagnostic capabilities, higher quality images, and shorter examination times.
   

The dual-energy X-ray absorptiometry market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Technology

• Axial DEXA bone densitometer
• Peripheral DEXA bone densitometer

Market, By Type

• Standalone
• Portable  

Market, By Application

• Osteoporosis
• Body composition analysis
• Fracture management
• Bone densitometry
• Other applications

Market, By End Use

• Hospitals and clinics
• Diagnostic centers
• Specialty centers
• Other end use

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE